Overview

Effect of Dotinurad in Hyperuricemia With Hypertension

Status:
RECRUITING
Trial end date:
2030-03-31
Target enrollment:
Participant gender:
Summary
The effect of dotinurad on CAVI (cardio-ankle vascular index) will be compared with that of febuxostat in patients with hyperuricemia complicated by hypertension.
Phase:
PHASE4
Details
Lead Sponsor:
Saga University
Treatments:
dotinurad
Febuxostat